AKBA — Akebia Therapeutics Share News
0.000.00%
Last trade - 00:00- $305.81m
- $337.17m
- $236.20m
Brief: Akebia Therapeutics Q3 basic EPS USD -0.08
Akebia Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Akebia Gets FDA Acceptance Of Resubmission To NDA Of Vadadustat
Brief: Akebia Announces Approval Of Vafseo In Australia And Provides Commercial Update
U.S. STOCKS ON THE MOVE-Domo, BlackBerry, Rite Aid
U.S. STOCKS ON THE MOVE-Decibel Therapeutics, Affirm Holdings, Medtronic
Akebia Therapeutics falls on weak Q2 results
Akebia Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Akebia Therapeutics Inc expected to post a loss of 2 cents a share - Earnings Preview
Brief: Akebia Therapeutics Inc - On Aug 11, Nasdaq Informed Co Is Not In Compliance With Nasdaq Listing Rule 5250(C)
Akebia Therapeutics Inc expected to post a loss of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Amylyx Pharma, Bakkt, Aptiv
Akebia Therapeutics falls on announcement of late second-quarter results
Brief: Akebia Therapeutics Provides Update On Form 10-Q Filing
Akebia Therapeutics Inc expected to post a loss of 2 cents a share - Earnings Preview
Akebia Therapeutics Inc expected to post a loss of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
U.S. STOCKS ON THE MOVE-Teladoc Health, NVDIA, Chipotle